Overview

Etoricoxib vs Aceclofenac in the Treatment of Patients With Rheumatoid Arthritis

Status:
Completed
Trial end date:
2007-07-31
Target enrollment:
0
Participant gender:
All
Summary
Comparison of lower dosage etoricoxib (60 mg daily) with aceclofenac (100 mg bid) for their efficacy and safety in the treatment of rheumatoid arthritis (RA).
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chung Shan Medical University
Treatments:
Aceclofenac
Diclofenac
Etoricoxib
Criteria
Inclusion Criteria:

- Diagnosis as Rheumatoid Arthritis

Exclusion Criteria:

- 1. Pregnant or breast-feeding women. 2. Chemotherapy or radiation therapy in cancer
patients